Not every CEO can go to work every day knowing they have an opportunity to directly impact their own health as well as thousands of other patients. As a biologist, seasoned biotechnology executive, and 2011 kidney transplant recipient, Stan Rose is in the unique position to do just that.
Earlier this month Novartis (Basel, Switzerland) and Google (Mountain View, California) made headlines with an agreement between Alcon (Hünenberg, Switzerland), the eye care division of Novartis, and Google[x], a team within Google, to in-license Google's smart lens technology for all ocular medical uses. The agreement is aimed at finding new solutions to big global problems by marrying Alcon's expertise in physiology and visual performance of the eye with Google's advances in miniaturized electronics, low power chip design, and micro-fabrication capabilities.
Midwest healthcare startups reported $777 million in total investments across 139 companies just in the first half of 2014, according to the BioEnterprise Midwest Healthcare Venture Investment Report. The totals are the highest recorded for the region both in dollars of financing and number of companies funded since BioEnterprise (Cleveland) began compiling the report in 2005.
It's been called digital health, connected health, mobile health and everything in between. Not everyone has agreed on a name for the space yet, but the gist is the same, Gary Conkright told Medical Device Daily, referring to the marriage between the IT and healthcare industries.
